The Bull Rankings scorecard — our quality-growth score is 80 / 100, built from three pillars each graded 0–100 against sector peers: Quality 89, Growth 76, Value 75. At today's price, our reverse-DCF read says the market is implicitly betting on about -13% a year in free-cash-flow growth sustained for a decade — a gauge of how much optimism is already in the stock.
The thesis
Perdoceo’s stock is overvalued at $32.48. The market is pricing a free‑cash‑flow expansion of roughly ‑13% per year for a decade, yet the company is only delivering 11.7% revenue growth YoY and a 20.6% profit margin. That mismatch, combined with the model’s weakest pillar—Value at 75—means the price already embeds optimism that the business cannot sustain. Even a solid Quality score of 89 cannot offset a valuation that assumes a growth rate far below the implied multiple.
What the business actually is
Perdoceo runs three distinct higher‑education brands. Colorado Technical University (CTU) sells career‑oriented programs in business, nursing, cybersecurity, engineering and related fields. The American InterContinental University System (AIUS) focuses on business studies and information‑technology curricula. University of St. Augustine for Health Sciences (USAHS) delivers health‑science degrees, especially nursing and allied health. All three deliver courses through online, campus‑based and blended formats, targeting adult learners seeking professional credentials.
Why it can (or can't) keep compounding
The strongest signal from our model is Durable high returns. A ROE of 17.1% and a profit margin of 20.6% show the firm converts earnings into shareholder value efficiently. Low leverage—debt‑to‑equity of 0.11—gives it room to fund growth without stressing the balance sheet. The moat lies in its integrated delivery platform: each brand leverages a common LMS, accreditation infrastructure and marketing engine, making it costly for a new entrant to replicate the scale of enrollment pipelines across disparate career tracks. However, the Value pillar at 75 signals that the price multiple—PE 11.8 with a PEG of 0.7—is already generous given the modest growth outlook.
The valuation question
At a PE of 11.8 and a PEG of 0.7, the market is rewarding the stock for growth that is, in reality, only 11.7% year‑over‑year. Our reverse‑DCF shows the current price implies a ‑13% annual free‑cash‑flow decline for ten years. That is a paradox: the price is high enough to suggest shrinking cash flow, yet investors are paying a premium that assumes the opposite. The single‑analyst consensus target of $44—a 35% upside from today—relies on the belief that earnings will accelerate beyond the 11.7% trend, a view not supported by the latest fundamentals. In short, optimism is baked in; the valuation is not cheap.
The bear case
Skeptics can point to the widening gap between the implied FCF contraction and the actual profit margin. If cash conversion deteriorates, the free‑cash‑flow of $221 m could fall short of covering the $2.0 b market cap, forcing the company to dip into its modest debt capacity. A confirming signal would be a miss on the upcoming dividend increase or a pause in share buybacks, both of which the model currently flags as positive actions. Any reversal would expose the over‑optimistic growth assumptions and push the stock toward its 52‑week low of $26.66.
What would change our mind
A sustained revenue growth above 15% for two consecutive quarters would narrow the gap between actual performance and the reverse‑DCF’s implied decline, making the current multiple more defensible. Conversely, if the Value pillar slips below 70—for example, if the PE drifts above 13 while growth stalls—the overvaluation argument strengthens. Finally, a dividend cut or suspension of buybacks would signal management’s lack of confidence in cash generation, confirming the bear case. Until one of those thresholds flips, the stock remains priced for optimism it has yet to earn.